https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1265228/full
Objective: Major pathological response (MPR) helps evaluate the prognosis of patients with lung squamous cell carcinoma (LUSC). However, the clinical factors...
frontiersclinicalfactorsmajorpathological
https://pubmed.ncbi.nlm.nih.gov/31917067/
In clinical practice, global health was largely comparable to published clinical trials, but PRO-CTCAE items indicated a higher symptom prevalence. Closer...
patientreportedoutcomesreceivingimmunotherapy